Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Bacterial Infections and Mycoses

  Free Subscription


Articles published in Drugs

Retrieve available abstracts of 14 articles:
HTML format



Single Articles


    October 2022
  1. KHANNA S, Assi M, Lee C, Yoho D, et al
    Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
    Drugs. 2022;82:1527-1538.
    PubMed     Abstract available


    August 2022
  2. NGAN NTT, Flower B, Day JN
    Treatment of Cryptococcal Meningitis: How Have We Got Here and Where are We Going?
    Drugs. 2022;82:1237-1249.
    PubMed     Abstract available


    June 2022
  3. SHIRLEY M
    20-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults.
    Drugs. 2022;82:989-999.
    PubMed     Abstract available


  4. HOY SM
    Oteseconazole: First Approval.
    Drugs. 2022;82:1017-1023.
    PubMed     Abstract available


    March 2022
  5. CHOU A, Welch E, Hunter A, Trautner BW, et al
    Antimicrobial Treatment Options for Difficult-to-Treat Resistant Gram-Negative Bacteria Causing Cystitis, Pyelonephritis, and Prostatitis: A Narrative Review.
    Drugs. 2022;82:407-438.
    PubMed     Abstract available


    December 2021
  6. REYNOLDS D, Kollef M
    The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update.
    Drugs. 2021;81:2117-2131.
    PubMed     Abstract available


    October 2021
  7. HOENIGL M, Sprute R, Egger M, Arastehfar A, et al
    The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin.
    Drugs. 2021;81:1703-1729.
    PubMed     Abstract available


    September 2021
  8. SYED YY
    Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections.
    Drugs. 2021;81:1559-1571.
    PubMed     Abstract available


  9. HOY SM
    Contezolid: First Approval.
    Drugs. 2021;81:1587-1591.
    PubMed     Abstract available


    August 2021
  10. LEE A
    Ibrexafungerp: First Approval.
    Drugs. 2021;81:1445-1450.
    PubMed     Abstract available


  11. AARTS P, Dudink K, Vossen ARJV, van Straalen KR, et al
    Clinical Implementation of Biologics and Small Molecules in the Treatment of Hidradenitis Suppurativa.
    Drugs. 2021;81:1397-1410.
    PubMed     Abstract available


    July 2021
  12. LIN EY, Adamson PC, Klausner JD
    Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions.
    Drugs. 2021;81:1153-1169.
    PubMed     Abstract available


    February 2021
  13. ZHANEL GG, Deng C, Zelenitsky S, Lawrence CK, et al
    Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia.
    Drugs. 2021;81:233-256.
    PubMed     Abstract available


  14. HEO YA
    Imipenem/Cilastatin/Relebactam: A Review in Gram-Negative Bacterial Infections.
    Drugs. 2021;81:377-388.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: